Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

There exists a subpopulation of T2DM in whom first-line doses of statin are insufficient for optimally reducing LDL-C, representing a major risk of CVD. The RESEARCH study focuses on LDL-C reduction in this population along with modifications of the lipid profiles leading to residual risks.Lipid cha...

Full description

Bibliographic Details
Main Authors: Kentaro Sakamoto, Mitsunobu Kawamura, Takahide Kohro, Masao Omura, Takayuki Watanabe, Keiko Ashidate, Toshiyuki Horiuchi, Hidehiko Hara, Nobuo Sekine, Rina Chin, Motoyoshi Tsujino, Toru Hiyoshi, Motoki Tagami, Akira Tanaka, Yasumichi Mori, Takeshi Inazawa, Tsutomu Hirano, Tsutomu Yamazaki, Teruo Shiba, RESEARCH Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4580589?pdf=render

Internet

http://europepmc.org/articles/PMC4580589?pdf=render

Similar Items